The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RYTM FINANCIAL STATEMENTS

Rhythm Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

RYTMRhythm Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue239.9 M $Gross Profit213.5 M $ · 89%Operating Income-200.6 M $ · -84%Pre-tax Income-204.3 M $ · -85%Net Income to Owners-205.3 M $ · -86%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue239.9 M $+53.5%
Gross Profit213.5 M $+53.1%
Operating Income-200.6 M $—
EBITDA-184.7 M $—
Net Income to Owners-205.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets437.3 M
  • Equity217.3 M $50%
  • Current Liabilities123.6 M $28%
  • Long-term Liabilities96.4 M $22%

Key Figures

YoY change
Total Assets437.3 M $+17.3%
Total Liabilities220 M $-8.0%
Total Equity217.3 M $+62.7%
Cash & ST Investments330.9 M $+13.7%
Total Debt3.7 M $-12.1%
Net Debt-61.9 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-149.5 M $Operating-87.9 M $Investing174.4 M $Financing-63 M $Net Change

Key Figures

YoY change
Operating Cash Flow-149.5 M $—
Capital Expenditures953 K $-97.6%
Free Cash Flow-150.5 M $—
Dividends Paid1.4 M $-73.9%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RYTM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.